1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"TNBC Foundation–AACR NextGen Grant for Transformative Cancer Research 2026" is currently closed and not accepting applications.
TNBC Foundation–AACR NextGen Grant for Transformative Cancer Research 2026 is sponsored by TNBC Foundation and AACR. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Triple Negative Breast Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research - American Association for Cancer Research (AACR) Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Patient / Caregivers / Public Researchers / Professionals Home > Cancer Researchers / Other Health Care Professionals > Research Funding > Funded Research > Career Development Awards > Triple Negative Breast Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research Triple Negative Breast Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research The Triple Negative Breast Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research represent the AACR’s flagship funding initiative to stimulate highly innovative research from young investigators.
This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence. Icahn School of Medicine at Mount Sinai Branching Out: How do Basal-like Breast cancer Driver Mutations Initiate Hormone Independence?
Understanding the driver mutations behind basal-like breast cancer (BLBC) is crucial for developing molecular targeted therapies, as has been done for other breast cancer subtypes. While cancer genome projects have provided detailed characterizations of BLBC, the causal relationship between patient-derived genetic lesions and BLBC initiation and progression remains largely unclear.
Dr. Ying and his team utilized a novel in-utero lentivirus injection-based murine in vivo screening system to identify top drivers from 229 genetic lesions enriched in human BLBCs. Surprisingly, these drivers were found to initiate BLBC through an autocrine program that mimics the mammary branching signals typically activated by puberty hormones—despite the hallmark hormone independence of BLBC.
In the current project, they aim to uncover how this puberty-mimicking autocrine program is activated and whether inhibiting key signal hubs within this pathway can effectively suppress BLBC growth. Dr. Ying earned his doctorate at Sun Yat-sen University, focusing on oncogenic signaling in squamous cell carcinoma and lung cancer.
During his postdoctoral training at the Fred Hutchinson Cancer Center, he developed a rapid in vivo screening platform to identify breast cancer drivers and created advanced tools to study epithelial cell fate choice during cancer initiation. Dr. Ying is now an assistant Professor at the Icahn School of Medicine at Mount Sinai, where his team investigates epithelial cell fate choice in cancer and regeneration.
Acknowledgement of Support “It is a great honor for our team to receive the 2024 Triple Negative Breast Cancer Research Foundation-AACR NextGen Grant for Transformative Cancer Research. This support is crucial for advancing our efforts to understand how key driver lesions of triple-negative breast cancer hijack the fundamental mechanisms of mammary gland development.
” block needs to be placed in the location where the link block will be displayed--> Dr. Hani Goodarzi: Making Inroads in... Triple Negative Breast Cancer Research... Breast Cancer Research Foundation-AACR NextGen...
According to the current listing, eligibility includes: Early-career assistant professors, AACR members, focused on TNBC research. Confirm the full requirements in the official notice before applying.
The current listing shows $300,000 over three years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 14, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
TNBC Foundation–AACR NextGen Grant for Transformative Cancer Research 2026 is funded by TNBC Foundation and AACR. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.